
Loading, please wait...

Loading, please wait...

Borophene, a single layer of boron atoms, has recently captured the attention of the scientific community. This material exhibits a unique anisotropy in its crystallographic structure. Consequently, it demonstrates diverse physical and chemical behaviors. Borophene in biomedical applications is a growing field because of the material's high electronic mobility and chemical reactivity. While researchers have already explored metallic β and semiconducting α phases, new crystallographic phases are currently under investigation. These variations allow for specialized uses in next-generation medical devices.
Despite its potential, borophene faces significant hurdles before widespread clinical use. The synthesis process remains cumbersome and hinders the large-scale production of defect-free layers. Furthermore, the material is highly sensitive to oxidation and suffers from phase instability. Scientists are now implementing strategies like defect engineering and surface functionalization to address these issues. Additionally, 2D-2D hybridization offers a path for tuning the band gap and improving carrier injection. These refinements are essential for creating stable sensors and imaging tools.
Integration into medical devices involves resolving issues such as interfacial charging and work function mismatch. However, if researchers overcome these barriers, borophene could transform multiple specialties. Specifically, it holds promise for flexible batteries in wearable monitors and advanced biosensors for point-of-care diagnostics. Furthermore, its high surface area makes it an ideal candidate for targeted drug delivery systems. Therefore, the ongoing research into borophene stability is crucial for its eventual commercialization in the healthcare sector.
Borophene is lighter, more flexible, and possesses higher electronic mobility than graphene. These properties allow for more sensitive detection of biological molecules at trace levels.
Currently, researchers are studying its biocompatibility. Strategies like surface passivation and functionalization are being developed to reduce toxicity and prevent rapid oxidation in biological environments.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Always seek the advice of your physician or other qualified health provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Li Z et al. Borophene: Crucial Challenges and the Way Forward. Adv Sci (Weinh). 2026 Mar 15. doi: 10.1002/advs.202517082. PMID: 41833012.
Pan D et al. Chiralized Borophene for Biomedical Imaging and Targeted Delivery. ACS Nano. 2024 May 8. doi: 10.1021/acsnano.4c01792.
Blundell R. Revolutionary materials in medicine: Borophene, graphene, and graphite. Independent Malta. 2024 June 23.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A review of borophene's unique properties, current synthesis challenges, and its transformative potential in biomedical sensors and drug delivery....
7 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today